Tokyo, Japan

Shingo Tomemori

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nanomist Technologies Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shingo Tomemori. Retrieved from https://idiyas.com/inventor/shingo-tomemori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shingo Tomemori and Carbonate Salt Production

Introduction

Shingo Tomemori is an inventor based in Tokyo, Japan, associated with Nanomist Technologies Co., Ltd. His patent work addresses the production of carbonate salts by capturing carbon dioxide from exhaust gas.

Latest Patents

Tomemori is identified with 1 patent: “Method and Apparatus for Producing Carbonate Salts.” The invention describes atomizing an aqueous alkaline solution to create a mist, mixing that mist with exhaust gas so carbon dioxide is absorbed and reacts with positive ions, and separating the resulting carbonate-salt-containing mist from the gas. The method is intended to produce carbonate salts efficiently from carbon dioxide in exhaust emissions.

Career Highlights

The available information connects Tomemori’s inventive work with Nanomist Technologies Co., Ltd. His patent focuses on a process that combines gas treatment with the production of carbonate salts.

Collaborations

Tomemori’s listed coworkers include Kazuo Matsuura and Toshiharu Chichibu.

Conclusion

Shingo Tomemori’s patent presents a method for converting carbon dioxide in exhaust gas into carbonate salts through mist-based absorption and separation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…